Role of N6-Methyladenosine (m6A) RNA Modification in Multiple Myeloma

Bach C, Leffler M, Flamann C, Kronke J, Mougiakakos D, Mackensen A, Bruns H (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Blood American Society of Hematology

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

Event location: San Diego, CA US

DOI: 10.1182/BLOOD-2018-099-115820

Authors with CRIS profile

Christian Bach Department of Medicine 5 – Haematology and Oncology Cindy Flamann Department of Medicine 5 – Haematology and Oncology Dimitrios Mougiakakos Professur für Hämatologie/Onkologie mit dem Schwerpunkt Tumorimmunologie Andreas Mackensen Lehrstuhl für Innere Medizin V Heiko Bruns Department of Medicine 5 – Haematology and Oncology

Involved external institutions

Universitätsklinikum Ulm DE Germany (DE)

How to cite

APA:

Bach, C., Leffler, M., Flamann, C., Kronke, J., Mougiakakos, D., Mackensen, A., & Bruns, H. (2018). Role of N6-Methyladenosine (m6A) RNA Modification in Multiple Myeloma. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Bach, Christian, et al. "Role of N6-Methyladenosine (m6A) RNA Modification in Multiple Myeloma." Proceedings of the 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA WASHINGTON: AMER SOC HEMATOLOGY, 2018.

BibTeX: Download